PCRX 10-KFeb 26 '26
“We had three wholesalers each comprising 10 percent or more of our total revenue for the year ended December 31, 2025: McKesson Drug Company, Cardinal Health, Inc. and AmerisourceBergen Health Corporation, which accounted for 31%, 26% and 22% of our total revenues, respectively.”
LLY 10-KFeb 12 '26
“In 2025, 2024, and 2023, three wholesale distributors in the U.S.—McKesson Corporation, Cencora, Inc., and Cardinal Health, Inc.—each accounted for a significant percentage of our consolidated revenue.”
PCRX 10-KFeb 26 '26
“We had three wholesalers each comprising 10 percent or more of our total revenue for the year ended December 31, 2025: McKesson Drug Company, Cardinal Health, Inc. and AmerisourceBergen Health Corporation, which accounted for 31%, 26% and 22% of our total revenues, respectively.”
LLY 10-KFeb 12 '26
“In 2025, 2024, and 2023, three wholesale distributors in the U.S.—McKesson Corporation, Cencora, Inc., and Cardinal Health, Inc.—each accounted for a significant percentage of our consolidated revenue.”
| Stage | PCRX | % of rev | LLY | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $192M | 100.00% | $24.4B | 100.00% | LLY ×126.80 |
| Gross profit | $148M | 77.05% | $20.5B | 83.88% | LLY +6.8pp |
| Operating income | $4M | 2.22% | $8.6B | 35.28% | LLY +33.1pp |
| Pre-tax income | $3M | 1.33% | $8.4B | 34.46% | LLY +33.1pp |
| Net income | $5M | 2.42% | $6.5B | 26.44% | LLY +24.0pp |
| Stage | PCRX | LLY | Gap · A − B |
|---|---|---|---|
| Revenue | $192M100.00% | $24.4B100.00% | LLY ×126.80 |
| Gross profit | 77.05%$148M | 83.88%$20.5B | LLY +6.8pp |
| Operating income | 2.22%$4M | 35.28%$8.6B | LLY +33.1pp |
| Pre-tax income | 1.33%$3M | 34.46%$8.4B | LLY +33.1pp |
| Net income | 2.42%$5M | 26.44%$6.5B | LLY +24.0pp |